-The Telegraph New Delhi: A group of Indian doctors has urged the Narendra Modi government to resist any US government or industry pressure to reverse its decisions earlier this year to impose price caps on coronary stents and knee implants. The Association of Doctors for Ethical Practices (ADEH) said on Wednesday that it is hoping the Indian government will "remain firm" on its decision to cap the prices of the devices because...

-The Telegraph New Delhi: Health activists campaigning for affordable treatment on Wednesday urged the Narendra Modi government to resist "pressure" from foreign medical device makers and expand price caps to new classes of medical devices. The All India Drug Action Network (AIDAN), a consortium of non-government activists' groups, said it was concerned that a body of foreign medical device manufacturers had petitioned the US government seeking suspension or withdrawal of certain trade...

-Scroll.in But study of the pilot scheme also finds that 67% of respondents now prefer cash transfers. In three Union territories where the government is running an experimental project to distribute cash instead of subsidised foodgrains, a third of beneficiaries surveyed said they either had not received any money at all (with or without proof) or did not know if they had received it. This despite government claims that 99% of...

-The Hindu Business Line At an organic market in Odisha, middle-class consumers get to interact with the producers of their food and appreciate traditional knowledge systems One Sunday morning in January, I visited an organic produce market located amidst dense bougainvillea creepers and rows of trees, on the grounds of the six-decade-old Christian Hospital in Bissamcuttack, a town in western Odisha’s Rayagada district. In policy and public imagination, Odisha, particularly its western districts...

-The Times of India In a first for a medical device, the public interest provision in the Drug Price Control Order (DPCO) 2013 was used by the National Pharmaceutical Pricing Authority to cap the price of knee implants. The NPPA cited "exorbitant prices being charged from patients in a non-regulated market" and "a failed market system where asymmetry of information between patient and the doctor has resulted into unethical practices and...